Likewise, the pro-inflammatory cytokines TNF-α (Figure 4A), IL-1β (Figure 4B), and IL-6 (Figure 4C) were elevated (p < 0.001) and the anti-inflammatory IL-10 was decreased (Figure 4D; p < 0.001) following CIS administration. This evidence concerns the gene IL10 and in situ carcinoma.